Latest news
Reckitt Benckiser Group rises Friday, outperforms market - MarketWatchMarketWatch · Fri, 07 Aug 2026 16:07:00 GMTReckitt Benckiser: Core Brands Remain Undervalued Despite Mead Johnson Litigation Risk - Seeking AlphaSeeking Alpha · Fri, 07 Aug 2026 05:34:28 GMTReckitt announces U.S. FDA approval of Mucinex 12HR Cold & Fever Multi-Symptom, the first OTC innovation in the cold & flu category in 14 years - reckitt.comreckitt.com · Wed, 05 Aug 2026 13:09:07 GMTReckitt Benckiser Group (LON:RKT) Given New GBX 5,352 Price Target at Berenberg Bank - MarketBeatMarketBeat · Wed, 05 Aug 2026 10:08:45 GMTReckitt Announces Any and All Tender Offer and Consent Solicitation for Mead Johnson Nutrition Company Notes due 2044 - PR NewswirePR Newswire · Wed, 05 Aug 2026 10:07:00 GMTShould you buy shares in Reckitt Benckiser? - The TimesThe Times · Wed, 05 Aug 2026 08:21:10 GMTRECKITT BENCKISER GROUP PLC To Go Ex-Dividend On August 6th, 2026 With 1.19111 USD Dividend Per Share - MoomooMoomoo · Wed, 05 Aug 2026 01:00:02 GMTReckitt Benckiser picks Citi to run first tranche of buyback - marketscreener.commarketscreener.com · Tue, 04 Aug 2026 11:29:13 GMT